Monthly Active Users Reached Approximately 95.8 million; Up 20% Year-Over-Year Record Annual Global Net Additions of 576 thousand Paying Circles, ...

Delivered Adjusted EBITDA 1 of $2.73 billion in 2025, exceeding guidance, and representing an increase of 11% compared to 2024. Adjusted Net Income grew 15% to $1.045 billion. Adjusted EPS grew 19% to ...

Ruchir Sharma says gold's parabolic rally doesn't make sense, with investor coming up with stories that justify its rapid ...

A research report framed as a hypothetical look back from 2028 was making the rounds online and adding to fresh jitters in ...

Andrew Left says SanDisk is vulnerable to competition from Samsung, which has the power to flood the market with cheaper ...

Claude, Anthropic's AI chatbot, has sparked major selling of US tech stocks as its capabilities induce fear among investors ...

New tariffs chaos means investor should focus on AI and sectors of the S&P 500 that have outperformed this year, investing experts told Business Insider.

IBM shares tumbled after Anthropic unveiled a tool aimed at business that use a decades-old programming language ...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN ...

Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions, including kidney stones (known as ...

Earnings Release Highlights Full year GAAP Net Loss Attributable to Stockholders of $(219) million.Full year Adjusted EBITDA of $1,035 million ...

Gross margin reflects one-time costs of approximately $1.9 million, or 1% for the full-year 2025, related to the FDA BLA approval of Avance ®, of which 67% are non-cash and relate to the vesting of ...